Advances in mesenchymal stem cell research in sepsis

Area of Science:

• Regenerative Medicine
• Immunology
• Critical Care

Background:

• Sepsis poses significant postoperative morbidity and mortality risks.
• Current treatments include resuscitation and antimicrobials.
• Exogenous cell-based therapies, like mesenchymal stem cells (MSCs), are under investigation.

Purpose of the Study:

• To review the potential of mesenchymal stem cells (MSCs) in sepsis treatment.
• To explore MSC mechanisms and efficacy in preclinical sepsis models.

Main Methods:

• Literature search of PubMed for sepsis pathophysiology, MSC interactions, and animal trials.
• Focused on recent studies involving stem cells in sepsis treatment.

Main Results:

• MSCs home to injured tissues and secrete anti-inflammatory paracrine signals.
• They reduce apoptosis, stimulate healing, modulate immune cells, and possess antimicrobial properties.
• These actions lead to improved organ function and survival in animal sepsis models.

Conclusions:

• Animal models demonstrate MSCs' beneficial properties for sepsis.
• MSC homing and paracrine actions improve organ function and survival.
• Further research is needed to understand MSC-host interactions in sepsis.